Effectiveness and Safety of Ensitrelvir Fumaric Acid in Patients with Risk Factors for Severe COVID-19: A Randomized Controlled Trial of Ensitrelvir Compared with Molnupiravir

Authors

Institutions

Publication Details

Journal
Kansenshogaku zasshi
Published
2026-02-26
DOI
https://doi.org/10.11150/kansenshogakuzasshi.e25012
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness and Safety of Ensitrelvir Fumaric Acid in Patients with Risk Factors for Severe COVID-19: A Randomized Controlled Trial of Ensitrelvir Compared with Molnupiravir

Shintaro Tanaka, Takahiro Takazono, Makiko Kobayashi, Naoki Hosogaya et al.
Kansenshogaku zasshi
COVID-19 Clinical Research Studies
article

Effectiveness and Safety of Ensitrelvir Fumaric Acid in Patients with Risk Factors for Severe COVID-19: A Randomized Controlled Trial of Ensitrelvir Compared with Molnupiravir

Shintaro Tanaka, Takahiro Takazono, Makiko Kobayashi, Naoki Hosogaya, Hiroshi Mukae, Masahiro KINOSHITA
article en

Abstract

No abstract available for this paper.
Kansenshogaku zasshiVol. 100(2)
Shionogi (Japan) (JP), Nagasaki University Hospital (JP)
Good health and well-being
Openalex Percentile: Top 43%
COVID-19 Clinical Research Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.